Quantifying the Benefits of Digital Biomarkers and Technology-Based Study Endpoints in Clinical Trials: Project Moneyball
Introduction: Digital biomarkers have significant potential to transform drug development, but only a few have contributed meaningfully to bring new treatments to market. There are uncertainties in how they will generate quantifiable benefits in clinical trial performance and ultimately to the chanc...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Karger Publishers
2022-06-01
|
| Schriftenreihe: | Digital Biomarkers |
| Schlagworte: | |
| Online-Zugang: | https://beta.karger.com/Article/FullText/525255 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|